SEC
SlamSEC
SearchBrowseEarnings

Axogen, Inc.

Nasdaq:AXGN
Electromedical & Electrotherapeutic Apparatus·ALACHUA, FL
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(1000 total)

TypeDateAccessionPeriodSize
4
Mar 2, 2026
0000805928-26-000044FORM 4
Feb 26, 2026
11.6 KB
4
Mar 2, 2026
0000805928-26-000043FORM 4
Feb 26, 2026
11.2 KB
4
Mar 2, 2026
0000805928-26-000042FORM 4
Feb 26, 2026
15.4 KB
4
Feb 27, 2026
0000805928-26-000038FORM 4
Feb 26, 2026
9.3 KB
4
Feb 27, 2026
0000805928-26-000036FORM 4
Feb 26, 2026
6.0 KB
4
Feb 24, 2026
0000805928-26-000032FORM 4
Feb 22, 2026
9.3 KB
10-K
Feb 24, 2026
0000805928-26-000031FORM 10-K
Dec 31, 2025
10.3 MB
8-K
Feb 24, 2026
0000805928-26-000028FORM 8-K
Feb 24, 2026
2.6 MB
8-K
Jan 23, 2026
0000805928-26-0000268-K
Jan 21, 2026
639.7 KB
424B5
Jan 23, 2026
0000805928-26-000025424B5
—
1.6 MB
424B5
Jan 21, 2026
0000805928-26-000018424B5
—
1.4 MB
S-3ASR
Jan 21, 2026
0000805928-26-000013S-3ASR
—
1.3 MB
8-K
Jan 12, 2026
0000805928-26-000004FORM 8-K
Jan 12, 2026
4.7 MB
4
Dec 17, 2025
0001400568-25-000005FORM 4
Dec 16, 2025
18.2 KB
4
Dec 17, 2025
0000805928-25-000177FORM 4
Dec 16, 2025
14.9 KB
4
Dec 17, 2025
0000805928-25-000176FORM 4
Dec 15, 2025
8.8 KB
144
Dec 16, 2025
0001950047-25-010428
—
4.8 KB
144
Dec 16, 2025
0001950047-25-010395
—
5.4 KB
144
Dec 15, 2025
0001950047-25-010364
—
5.5 KB
4
Dec 12, 2025
0000805928-25-000171FORM 4
Dec 10, 2025
4.7 KB
4
Dec 12, 2025
0000805928-25-000170FORM 4
Dec 11, 2025
4.6 KB
144
Dec 11, 2025
0001950047-25-010129
—
6.1 KB
4
Dec 10, 2025
0000805928-25-000167FORM 4
Dec 9, 2025
5.5 KB
4
Dec 10, 2025
0000805928-25-000166FORM 4
Dec 9, 2025
13.6 KB
4
Dec 10, 2025
0000805928-25-000165FORM 4
Dec 9, 2025
5.5 KB
25 filings shown

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage.

CEO
Dale Michael D
CFO
Hartley Lindsey Marie